Alliancebernstein L.P. Immunocore Holdings PLC Transaction History

Alliancebernstein L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$60.14 - $75.36 $1.44 Million - $1.81 Million	23,970 Added 32.65%	97,381 $6.33 Million
Q4 2023 Feb 14, 2024	SELL	$42.85 - $69.5 $2.02 Million - $3.28 Million	-47,183 Reduced 39.13%	73,411 $5.02 Million
Q3 2023 Nov 14, 2023	BUY	$49.5 - $66.6 $3.48 Million - $4.68 Million	70,238 Added 139.48%	120,594 $6.26 Million
Q2 2023 Aug 15, 2023	BUY	$48.54 - $61.64 $2.44 Million - $3.1 Million	50,356 New	50,356 $3.02 Million

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.